Format

Send to

Choose Destination
J Am Coll Cardiol. 2020 Feb 18;75(6):632-647. doi: 10.1016/j.jacc.2019.11.055.

Salt Reduction to Prevent Hypertension and Cardiovascular Disease: JACC State-of-the-Art Review.

Author information

1
Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom. Electronic address: f.he@qmul.ac.uk.
2
Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
3
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

Abstract

There is strong evidence for a causal relationship between salt intake and blood pressure. Randomized trials demonstrate that salt reduction lowers blood pressure in both individuals who are hypertensive and those who are normotensive, additively to antihypertensive treatments. Methodologically robust studies with accurate salt intake assessment have shown that a lower salt intake is associated with a reduced risk of cardiovascular disease, all-cause mortality, and other conditions, such as kidney disease, stomach cancer, and osteoporosis. Multiple complex and interconnected physiological mechanisms are implicated, including fluid homeostasis, hormonal and inflammatory mechanisms, as well as more novel pathways such as the immune response and the gut microbiome. High salt intake is a top dietary risk factor. Salt reduction programs are cost-effective and should be implemented or accelerated in all countries. This review provides an update on the evidence relating salt to health, with a particular focus on blood pressure and cardiovascular disease, as well as the potential mechanisms.

KEYWORDS:

blood pressure; cardiovascular disease; dietary salt; dietary sodium

PMID:
32057379
DOI:
10.1016/j.jacc.2019.11.055

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center